TY  - JOUR
AU  - Jimenez-Cortegana, Carlos
AU  - Palazon-Carrion, Natalia
AU  - Martin Garcia-Sancho, Alejandro
AU  - Nogales-Fernandez, Esteban
AU  - Carnicero-Gonzalez, Fernando
AU  - Rios-Herranz, Eduardo
AU  - de la Cruz-Vicente, Fatima
AU  - Rodriguez-Garcia, Guillermo
AU  - Fernandez-Alvarez, Ruben
AU  - Rueda Dominguez, Antonio
AU  - Casanova-Espinosa, Maria
AU  - Martinez-Banaclocha, Natividad
AU  - Guma-Padro, Josep
AU  - Gomez-Codina, Jose
AU  - Labrador, Jorge
AU  - Salar-Silvestre, Antonio
AU  - Rodriguez-Abreu, Delvys
AU  - Galvez-Carvajal, Laura
AU  - Provencio, Mariano
AU  - Sanchez-Beato, Margarita
AU  - Guirado-Risueño, Maria
AU  - Espejo-Garcia, Pablo
AU  - Lejeune, Marylene
AU  - Alvaro, Tomas
AU  - Sanchez-Margalet, Victor
AU  - de la Cruz-Merino, Luis
PY  - 2021
DO  - 10.1136/jitc-2020-002323
UR  - http://hdl.handle.net/10668/18034
T2  - Journal for immunotherapy of cancer
AB  - The search for immunological markers with ability of predicting clinical outcome is a priority in lymphomas, and in cancer in general. It is well known that some immunomodulatory cells, such as myeloid derived suppressor cells (MDSCs) or regulatory T...
LA  - en
PB  - BMJ Group
KW  - Cellular
KW  - Biomarkers
KW  - Immunity
KW  - Immunomodulation
KW  - Immunotherapy
KW  - Myeloid-derived suppressor cells
KW  - Tumor
KW  - Área de Gestión Sanitaria Sur de Sevilla
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - Case-Control Studies
KW  - Clinical Trials as Topic
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Myeloid-Derived Suppressor Cells
KW  - Programmed Cell Death 1 Receptor
KW  - Survival Analysis
KW  - T-Lymphocytes, Regulatory
KW  - Treatment Outcome
TI  - Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
TY  - research article
VL  - 9
ER  -